Dalia H. Kashef-El

Al Mansurah, DK 35516, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Methylsulfonylmethane Attenuates Dexamethasone-Induced Hepatic Insulin Resistance in Rats: Associations with SGK1, p-AMPK/mTOR, Inflammatory and Angiogenic Markers.

Methylsulfonylmethane Attenuates Dexamethasone-Induced Hepatic Insulin Resistance in Rats: Associations with SGK1, p-AMPK/mTOR, Inflammatory and Angiogenic Markers.

Journal: Journal of xenobiotics

Published: May 26, 2026

Febuxostat attenuates chronic kidney disease induced by adenine in rats: role of TLR4/NF-κB/NLRP3/Caspase1/IL-1β pathway.

Febuxostat attenuates chronic kidney disease induced by adenine in rats: role of TLR4/NF-κB/NLRP3/Caspase1/IL-1β pathway.

Journal: Inflammopharmacology

Published: March 27, 2026

Diacerein protects against thioacetamide-induced acute liver injury via modulating HMGB1/TLR4/MyD88/NF-κB signaling pathway.

Diacerein protects against thioacetamide-induced acute liver injury via modulating HMGB1/TLR4/MyD88/NF-κB signaling pathway.

Journal: Toxicology and applied pharmacology

Published: February 15, 2026

Diacerein protects against thioacetamide-induced acute liver injury via modulating HMGB1/TLR4/MyD88/NF-κB signaling pathway.

Diacerein protects against thioacetamide-induced acute liver injury via modulating HMGB1/TLR4/MyD88/NF-κB signaling pathway.

Journal: Toxicology and applied pharmacology

Published: February 15, 2026

Agmatine Attenuates Methotrexate-Induced Hepatotoxicity: Targeting Oxidative Stress, Inflammation, and Apoptotic Pathways.

Agmatine Attenuates Methotrexate-Induced Hepatotoxicity: Targeting Oxidative Stress, Inflammation, and Apoptotic Pathways.

Journal: Journal of biochemical and molecular toxicology

Published: December 07, 2025

Pirfenidone ameliorates dexamethasone-induced steatohepatitis and vascular resistance in rats.

Pirfenidone ameliorates dexamethasone-induced steatohepatitis and vascular resistance in rats.

Journal: Life sciences

Published: December 01, 2025

Secukinumab mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-ERK/p-eIF2α/CHOP and NLRP3/Caspase-1/IL-1β pathways.

Secukinumab mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-ERK/p-eIF2α/CHOP and NLRP3/Caspase-1/IL-1β pathways.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 29, 2025

Ruxolitinib attenuates diethylnitrosamine-induced liver injury in mice: involvement of TLR4/MYD88/NF-κB and IL-6/JAK/STAT pathways.

Ruxolitinib attenuates diethylnitrosamine-induced liver injury in mice: involvement of TLR4/MYD88/NF-κB and IL-6/JAK/STAT pathways.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: November 23, 2025

Vonoprazan mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-AMPK/ SIRT1/ PGC-1α and Keap1/Nrf2/HO-1 pathways.

Vonoprazan mitigates diethyl nitrosamine-induced acute liver injury in mice via modulating p-AMPK/ SIRT1/ PGC-1α and Keap1/Nrf2/HO-1 pathways.

Journal: Life sciences

Published: August 27, 2025

Ezetimibe counteracts lipopolysaccharide-induced liver injury in mice via modulating TLR4-mediated MYD88/TRAF-6/NF-kB signaling pathway.

Ezetimibe counteracts lipopolysaccharide-induced liver injury in mice via modulating TLR4-mediated MYD88/TRAF-6/NF-kB signaling pathway.

Journal: Toxicology and applied pharmacology

Published: August 20, 2025

Acriflavine protects against LPS-induced sepsis via regulation of pyroptosis, inflammation, and endoplasmic reticulum stress.

Acriflavine protects against LPS-induced sepsis via regulation of pyroptosis, inflammation, and endoplasmic reticulum stress.

Journal: Human & experimental toxicology

Published: July 12, 2025

Attenuating amiodarone-induced lung toxicity by the vitamin D receptor activator paricalcitol in rats: targeting TLR4/NF-κB/HIF-1α and TGF-β/Smad signaling pathways.

Attenuating amiodarone-induced lung toxicity by the vitamin D receptor activator paricalcitol in rats: targeting TLR4/NF-κB/HIF-1α and TGF-β/Smad signaling pathways.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 22, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026